New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
12:26 EDTZMHZimmer down slightly after FDA recalls PEEK Ardis Inserter
The FDA announced that it was issuing a Class I recall for Zimmer Spine's (ZMH) PEEK Ardis Inserter. A Class I recall is issued when the FDA believes that there is a reasonable probability that the use of a product could cause serious health problems. The device is used to insert Zimmer's PEEK Ardis Interbody Spacer during spinal surgery. Zimmer was told that the spacer has broken into fragments when too much lateral force is applied to the inserter in some cases, the FDA reported. As a result, patients may experience various adverse effects, including a tear in the thin covering of the spinal cord, cerebrospinal fluid leakage, significant blood loss and nerve injury, according to the agency. Long-term health risks may include disability, dysfunction, or death, it added. The FDA's recall was initiated on December 21. Zimmer, on December 20, had initiated a voluntary recall of all 315 of its PEEK inserter units. Zimmer said at that time that it had received reports of the spacer implant breaking, but did not list adverse health effects that could occur if the implant breaks. In early afternoon trading, Zimmer fell 38c, or 0.57%, to $66.35.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
14:48 EDTZMHZimmer, Stryker have mixed read through from J&J results, says Wells Fargo
Subscribe for More Information
April 13, 2015
17:07 EDTZMHZimmer announces extension of outside date for pending Biomet merger
Subscribe for More Information
April 9, 2015
09:25 EDTZMHBiomet results positive for Zimmer deal accretion, says Wells Fargo
Wells Fargo says the key takeaway from Bioment's Q3 results this morning was the company's "significant" margin improvement. The results give Wells more confidence that Zimmer's earnings accretion estimate for the acquisition is attainable and could mean potential upside.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use